1. FDA 2003. Draft. Guidance for Industry. Pharmacogenomic Data Submissions. Draft Guidance. Washington DC:Food and Drug Administration. Available: www.fda.gov/cder/guidance/5900dft.pdf [accessed 26 July 2004].
2. FDA 2004. FDA Mission Statement. 2004. Washington DC:U.S. Food and Drug Administration. Available: http://www.fda.gov/opacom/morechoices/mission.html [accessed 26 July 2004].
3. FDA/DIA 2004. Co-Development of Drug Biological and Device Products 29 July 2004 Arlington VA. Washington DC:U.S. Food and Drug Administration/Horsham PA:Drug Information Association. Available: http://www.diahome.org/Content/Events/04040.pdf [accessed 26 July 2004].
4. Pharmacogenomic data submissions to the FDA: non-clinical case studies
5. Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies